Topical Gene Therapy Gets Priority Review for Dystrophic Epidermolysis Bullosa
B-VEC is an investigational topical gene therapy designed to deliver 2 copies of the COL7A1 gene when applied directly to DEB wounds.
Dermatology
And Then Came Monkeypox: What to Know About the Recent Outbreak
In this interview, Paritosh Prasad, MD, provides insight into the recent outbreak of monkeypox.
Hyperbaric Oxygen Therapy in the Management of Chronic Wounds
Authors review the indications and contraindications, as well as the risks and benefits, of hyperbaric oxygen therapy in chronic wound management.
Otezla Now Approved for Plaque Psoriasis Across All Severities
The approval was based on data from the phase 3 ADVANCE trial.
Clinical Challenge: Progression of Palpable Purpura to Bullous Plaques
A 20-year-old woman presents to the dermatology clinic with a 5-day history of a mildly pruritic rash on both of her legs and feet. Can you diagnose this condition?
Calciphylaxis Prevention and Treatment Strategies
Calciphylaxis treatment should include a multimodal approach with a focus on supportive care, infection prevention, pain management, and wound healing.
DermDx: Drop-Like Lesions on Back and Chest
A 29-year-old man presents to the dermatology clinic for evaluation of a rash on his body that began 2 weeks ago. Can you make the diagnosis?
Several Topical Meds Can Lead to Allergic Contact Dermatitis
Previously unrecognized pathogenic mechanisms involving ocular contact dermatitis has driven new approaches to control the inflammatory process.
Atopic Dermatitis in Black Patients: Societal and Biologic Causes
Clinician competence in treating patients of various racial and ethnic backgrounds and the critical need for greater inclusion of diverse populations in trials investigating the pathophysiology and treatment of AD are underscored.
Increased Risk of Skin Cancer Linked to Long-Term Use of Certain Diuretics
A team of investigators sought to assess the relationship between thiazides, thiazide-like diuretics, or calcium channel blockers and the development of basal cell carcinoma, squamous cell carcinoma, or cutaneous malignant melanoma.
- Loading...
Loading...
Loading... 
Loading...